Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin.
Continuous evolution of magnetic resonance imaging in multiple sclerosis.
The role of N-Glycan modification of TNFR1 in inflammatory microglia activation.
Iron chelation in the treatment of neurodegenerative diseases.
[Multimodal complex treatment in advanced multiple sclerosis.]
Neurodegeneration: From Multiple Sclerosis to Alzheimer's Disease.
Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis.
Disseminated Encephalomyelitis-Like Central Nervous System Neoplasm in Childhood.
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level-NO.
[Differential diagnosis of optic neuritis (review].
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.
Ultra-high field MRI: looking through the 'macroscope'
Immune cell dynamics in the CNS: Learning from the zebrafish.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu).
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
The breakdown of myelin-bound proteins by intra- and extracellular proteases.
Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions.
What's in the Literature?
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
Cerebral venous thrombosis in a patient with clinically isolated spinal cord syndrome.
Lesion Activity on Brain MRI in a Chinese Population with Unilateral Optic Neuritis.
Increasing consistency of disease biomarker prediction across datasets.
An unusually dry story.
Retrograde degeneration of visual pathway: hemimacular thinning of retinal ganglion cell layer in progressive and active multiple sclerosis.
Pages
« first
‹ previous
…
511
512
513
514
515
516
517
518
519
…
next ›
last »